NURS πŸ“ˆ Hydreight Technologies - Overview

Exchange: V • Country: United States • Currency: CAD • Type: Common Stock •

NURS: Health, Wellness, Consulting, Pharmaceutical, App, Insurance, Services

Hydreight Technologies Inc. provides mobile health and wellness services primarily in the United States. Its Hydreight App offers consulting and advising in setting up their health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides to various services, such as Botox, fillers, etc.; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. The company operates health related application, as well as involved in pharmaceutical sales. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada. Web URL: https://hydreight.com

Additional Sources for NURS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

NURS Stock Overview

Market Cap in USD 31m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception

NURS Stock Ratings

Growth 5y 38.6%
Fundamental 5.49%
Dividend -
Rel. Strength Industry 14981
Analysts -
Fair Price Momentum 1.60 CAD
Fair Price DCF -

NURS Dividends

No Dividends Paid

NURS Growth Ratios

Growth Correlation 3m 95.5%
Growth Correlation 12m 18.8%
Growth Correlation 5y -41.1%
CAGR 5y 51.53%
CAGR/Mean DD 5y 1.13
Sharpe Ratio 12m 1.62
Alpha 241.50
Beta -0.10
Volatility 242.71%
Current Volume 86.6k
Average Volume 20d 161.8k
What is the price of NURS stocks?
As of December 22, 2024, the stock is trading at CAD 1.53 with a total of 86,616 shares traded.
Over the past week, the price has changed by +34.62%, over one month by +122.22%, over three months by +483.33% and over the past year by +351.61%.
Is Hydreight Technologies a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Hydreight Technologies is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.49 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NURS as of December 2024 is 1.60. This means that NURS is currently overvalued and has a potential downside of 4.58%.
Is NURS a buy, sell or hold?
Hydreight Technologies has no consensus analysts rating.
What are the forecast for NURS stock price target?
According to ValueRays Forecast Model, NURS Hydreight Technologies will be worth about 1.7 in December 2025. The stock is currently trading at 1.53. This means that the stock has a potential upside of +13.07%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1.7 13.1%